DarioHealth (DRIO)
(Delayed Data from NSDQ)
$0.53 USD
-0.02 (-3.62%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.53 0.00 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DRIO 0.53 -0.02(-3.62%)
Will DRIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DRIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DRIO
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates
TransMedics (TMDX) Q2 Earnings and Revenues Surpass Estimates
DRIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know
Other News for DRIO
DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025 | DRIO Stock News
DRIO Stock Sale Proceeds to Exclude Company Earnings
DarioHealth files to sell 8.77M shares of common stock for holders
DarioHealth files to sell 8.77M shares of common stock for holders
DarioHealth (DRIO) Partners with GreenKey Health to Revolutionize Sleep Care Market | DRIO ...